ARCH Venture Partners

United States
ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs, concentrating on bringing to market innovations in life sciences. They enjoy special recognition as a leader in the successful commercialization of technologies developed at academic research institutions and national laboratories. ARCH has raised ten venturefunds totaling over $3 billion and has invested in the earliest venture capital rounds for more than 150 companies. ARCH investors include major corporations, pension funds, endowment funds, financial institutions, and private investors.
Founded:1986
Firm Location:United States • New York • Wisconsin • New York, New York • Chicago, Illinois • San Diego, California • San Francisco, California • Seattle, Washington • Washington, District of Columbia • Boston, Massachusetts • Cambridge, Massachusetts • Palo Alto, California • Encinitas, California • Menlo Park, California • San Carlos, California • San Francisco Bay Area
ARCH Venture Partners Team
Photo of Brett Battles, Venture Partner at ARCH Venture Partners
Brett Battles
ARCH Venture Partners·Venture Partner
Sweet spot: $2.0M
Range: $500K - $5.0M
Investors in Palo Alto (CA)
Investors in BioTech, Investors in Consumer Health, Investors in DeepTech, Investors in Digital Health, Investors in Enterprise Infrastructure, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health IT, Investors in San Francisco Bay Area (Other Lists)
Photo of Jake Bauer, Venture Partner at ARCH Venture Partners
Jake Bauer
ARCH Venture Partners·Venture Partner
Sweet spot: $25.0M
Range: $50K - $50.0M
Investors in San Francisco (CA), Investors in Chicago (IL), Investors in Dublin (Ireland), Investors in Seattle (WA)
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists)
Photo of Paul Berns, Managing Director at ARCH Venture Partners
Paul Berns
ARCH Venture Partners·Managing Director
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Wisconsin, Investors in Palo Alto (CA)
Investors in BioTech, Investors in Pharmaceuticals
Photo of Reetika Bhardwaj, Associate at ARCH Venture Partners
Reetika Bhardwaj
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Chicago (IL)
Investors in BioTech, Investors in Health & Hospital Services, Investors in Health IT, Investors in Midwest (Other Lists), Investors in Pharmaceuticals
Photo of Luciana Borio, Venture Partner at ARCH Venture Partners
Luciana Borio
ARCH Venture Partners·Venture Partner
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Seattle (WA), Investors in Dublin (Ireland), Investors in SF Bay Area (CA), Investors in Chicago (IL)
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in Washington, D.C. (Other Lists)
Photo of Kristina Burow, Managing Director at ARCH Venture Partners
Kristina Burow
ARCH Venture Partners·Managing Director
Sweet spot: $50K
Range: $50K - $150.0M
Investors in SF Bay Area (CA)
Investors in AgTech, Investors in AgTech, Investors in BioTech, Investors in BioTech, Investors in Diverse Investors (Other Lists), Investors in Female Investors (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Kristina Burow, Managing Director at ARCH Venture Partners
Kristina Burow
ARCH Venture Partners·Managing Director
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in United States
Investors in BioTech, Investors in Consumer Health, Investors in Medical Devices
Photo of Keith Crandell, Managing Director at ARCH Venture Partners
Keith Crandell
ARCH Venture Partners·Managing Director
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Chicago (IL)
Investors in BioTech, Investors in Chemicals, Investors in Medical Devices, Investors in Midwest (Other Lists), Investors in Semiconductors, Investors in SMB Software
Photo of David Cruikshank, Partner at ARCH Venture Partners
David Cruikshank
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Chicago (IL)
Investors in BioTech, Investors in Medical Devices, Investors in Midwest (Other Lists), Investors in Semiconductors
Photo of Inca Dieterich, Associate at ARCH Venture Partners
Inca Dieterich
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in United States
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT
Photo of Su Fu, Senior Associate at ARCH Venture Partners
Su Fu
ARCH Venture Partners·Senior Associate
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in San Francisco (CA)
Investors in BioTech, Investors in Enterprise, Investors in Health & Hospital Services, Investors in Health IT, Investors in San Francisco Bay Area (Other Lists)
Photo of Steven Gillis, Managing Director at ARCH Venture Partners
Steven Gillis
ARCH Venture Partners·Managing Director
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Seattle (WA)
Investors in BioTech, Investors in Pharmaceuticals, Investors in Seattle / Portland (Other Lists)
Photo of Richard Heyman, Venture Partner at ARCH Venture Partners
Richard Heyman
ARCH Venture Partners·Venture Partner
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Encinitas (CA)
Photo of Joseph Jeong, Venture Partner at ARCH Venture Partners
Joseph Jeong
ARCH Venture Partners·Venture Partner
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Palo Alto (CA)
Investors in BioTech, Investors in ClimateTech/CleanTech, Investors in EnergyTech, Investors in Manufacturing, Investors in San Francisco Bay Area (Other Lists), Investors in Semiconductors
Photo of Sean Kendall, Principal at ARCH Venture Partners
Sean Kendall
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Chicago (IL)
Investors in BioTech, Investors in Chemicals, Investors in EnergyTech, Investors in Midwest (Other Lists), Investors in Semiconductors
Photo of Jay Kocherlakota, Senior Associate at ARCH Venture Partners
Jay Kocherlakota
ARCH Venture Partners·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in San Francisco (CA), Investors in Dublin (Ireland), Investors in Seattle (WA), Investors in Chicago (IL)
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists)
Photo of Keith Lenden, Venture Partner at ARCH Venture Partners
Keith Lenden
ARCH Venture Partners·Venture Partner
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in San Francisco (CA), Investors in San Carlos (CA)
Investors in BioTech, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists)
Photo of Jonathan Lim, Venture Partner at ARCH Venture Partners
Jonathan Lim
ARCH Venture Partners·Venture Partner
Sweet spot: $25.0M
Range: $50K - $50.0M
Investors in Dublin (Ireland), Investors in San Francisco (CA), Investors in Seattle (WA), Investors in Chicago (IL)
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Los Angeles / Southern California (Other Lists), Investors in Medical Devices, Investors in Pharmaceuticals
Photo of Jay Markowitz, Partner at ARCH Venture Partners
Jay Markowitz
Sweet spot: $25.0M
Range: $50K - $25.0M
Investors in New York
Investors in BioTech, Investors in Pharmaceuticals
Photo of Mark McDonnell, Managing Director at ARCH Venture Partners
Mark McDonnell
ARCH Venture Partners·Managing Director
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Chicago (IL)
Investors in BioTech, Investors in Consumer Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in Midwest (Other Lists), Investors in Pharmaceuticals
Photo of Scott Minick, Venture Partner at ARCH Venture Partners
Scott Minick
ARCH Venture Partners·Venture Partner
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in SF Bay Area (CA)
Photo of Peter Mintun, Associate at ARCH Venture Partners
Peter Mintun
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Dublin (Ireland), Investors in Seattle (WA), Investors in Chicago (IL), Investors in Boston (MA)
Investors in BioTech, Investors in Boston / New England (Other Lists), Investors in Consumer Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in Pharmaceuticals
Photo of Robert Nelsen, Managing Director at ARCH Venture Partners
Robert Nelsen
ARCH Venture Partners·Managing Director
Sweet spot: $75.0M
Range: $50K - $150.0M
Investors in SF Bay Area (CA), Investors in Chicago (IL), Investors in Seattle (WA), Investors in Global
Photo of Ari Nowacek, Principal at ARCH Venture Partners
Ari Nowacek
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Seattle (WA)
Investors in BioTech, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in Seattle / Portland (Other Lists)
Photo of Sabah Oney, Venture Partner at ARCH Venture Partners
Sabah Oney
ARCH Venture Partners·Venture Partner
Sweet spot: $150K
Range: $100K - $5.0M
Investors in Chicago (IL), Investors in Dublin (Ireland), Investors in San Francisco (CA), Investors in Seattle (WA)
Investors in BioTech, Investors in BioTech, Investors in Consumer Health, Investors in Consumer Health, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Medical Devices, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists)
Photo of Jay Parrish, Venture Partner at ARCH Venture Partners
Jay Parrish
ARCH Venture Partners·Venture Partner
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in San Francisco (CA), Investors in United States
Investors in BioTech, Investors in Pharmaceuticals
Photo of Corey Ritter, Senior Associate at ARCH Venture Partners
Corey Ritter
ARCH Venture Partners·Senior Associate
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Chicago (IL)
Investors in BioTech, Investors in Diagnostics, Investors in Manufacturing, Investors in Material Science, Investors in Medical Devices, Investors in Midwest (Other Lists), Investors in Robotics
Photo of Vicki Sato, Venture Partner at ARCH Venture Partners
Vicki Sato
ARCH Venture Partners·Venture Partner
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in Cambridge (MA)
Investors in BioTech, Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals
Photo of Carol Suh, Partner at ARCH Venture Partners
Carol Suh
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in SF Bay Area (CA)
Investors in BioTech, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists)
Photo of Nilay Thakar, Senior Associate at ARCH Venture Partners
Nilay Thakar
ARCH Venture Partners·Senior Associate
Sweet spot: $25.0M
Range: $50K - $150.0M
Investors in United States
Investors in BioTech